ClinicalTrials.gov
public full text
Public Domain
Bioavailability and Bioequivalence Study of Two Different Sources of Opicapone
The purpose of this study is to evaluate the bioavailability and the bioequivalence between two active pharmaceutical ingredient (API) sources of opicapone (OPC) at two different dosage strengths (25 mg and 50 mg) after a single oral dose administration under fasting conditions in healthy male and female subjects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Dosage Form Proportionality of Opicapone To-Be-Marketed Formulation#827983
- Relative Bioavailability and Bioequivalence of Opicapone#1030628
- Bioequivalence Study of Furosemide 80mg Tablets Under Fasting Conditions#854706
- Fasting Study of Olmesartan Medoxomil Tablets 40 mg and Benicar® Tablets 40 mg#1008398
- Effect of Food on Opicapone#894856
Record · ID 994574
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive